Answers are grounded in this paper and cite their sources.
AimRenal function is associated with medication errors and related severe adverse events.The study's objective was to explore the availability of renal function tests in Dutch community pharmacies to be used for medication safety surveillance in accordance with data sharing regulations of clinical laboratory tests as of August 1, 2013. MethodsA retrospective cross sectional descriptive study was performed using data from the PHARMO Database Network (including general practitioner, community pharmacy and clinical laboratory data).Patients with an impaired renal function (<60 MDRD ml/min/1.73m2)without the use of risk medication, or patients with an impaired renal function (<50 MDRD ml/min/1.73m2)with the use of risk medication were selected from five community pharmacies included in the PHARMO Database Network and data collection on site (in the community pharmacy) was performed to determine the available information at the pharmacy. Results549 patients with a reduced kidney function were included in this study of which 273 without risk medication and 276 with risk medication.For 37% of patients with available information on impaired renal function in the PHARMO Database Network, this information was also available in community pharmacies.This was 52% for patients using risk medication with an impaired renal function.Percentages in the presence of available information varied from 16% to 77% between pharmacies. ConclusionThe presence of available information on renal function in community pharmacies was insufficient for patients with renal impairment.This hinders effective medication surveillance.The variation in information present in the pharmacies might depend on the willingness of patients to share laboratory measures with their community pharmacists as well as the willingness of prescribers and laboratories to share the information.Future research should examine which factors are independently associated with the presence of available information and should be used for interventions focusing on improving information exchange with the community pharmacy.
No takes yet. Share an insight, caveat, or question.
Elisabeth Smits (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: